GRANULES vs HESTERBIO: Stock Comparison

GRANULES INDIA vs HESTER BIOSCIENCESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows lower leverage and a higher ROCE, while HESTER BIOSCIENCES shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 4; HESTERBIO leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESHESTERBIO

Valuation lens

What price are you paying?

Market CapContext only
₹21,073 Cr
₹2,025 Cr
P/E RatioHESTERBIO has the lower reading
31.03x
14.27x
P/B RatioGRANULES has the lower reading
4.08x
5.4x
EPSHESTERBIO has the higher reading
₹2.9
₹17.29
Book ValueContext only
₹205.21
₹432.34
Dividend YieldHESTERBIO has the higher reading
0.21%
0.46%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹21,073 Cr vs ₹2,025 Cr
P/E Ratio
HESTERBIO has a lower P/E
14.27x vs 31.03x
P/B Ratio
GRANULES has a lower P/B
4.08x vs 5.4x
EPS
HESTERBIO has higher earnings per share
₹17.29 vs ₹2.9
Dividend Yield
HESTERBIO has a higher dividend yield
0.46% vs 0.21%
Revenue Growth (TTM YoY)
HESTERBIO has faster revenue growth
38.2% vs 22.8%
EPS Growth (TTM YoY)
HESTERBIO has faster EPS growth
968.7% vs 31.3%
Qtr Sales Growth
HESTERBIO has stronger quarterly sales growth
-5.93% vs -45.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESHESTERBIO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESHESTERBIO
Live Price₹848.3₹2,405.4
Day Change-0.65%9.25%
Volume11.73 L93,542
52-Week High₹910₹2,683.6
52-Week Low₹507.3₹1,239.3
Distance from 52W High-6.78%-10.37%

Valuation

MetricGRANULESHESTERBIO
Market Cap₹21,073 Cr₹2,025 Cr
P/E Ratio31.03x14.27x
P/B Ratio4.08x5.4x
EPS₹2.9₹17.29
Book Value₹205.21₹432.34
Dividend Yield0.21%0.46%

Growth

MetricGRANULESHESTERBIO
Revenue Growth (TTM YoY)22.8%38.2%
EPS Growth (TTM YoY)31.3%968.7%
Qtr Sales Growth-45.7%-5.93%
Qtr Profit Growth-60.13%-84.79%

Profitability & Leverage

MetricGRANULESHESTERBIO
ROE11.7%15.63%
ROCE12.47%9.19%
Net Margin11.15%16.73%
Operating Margin16.76%24.17%
Debt to Equity0.26x0.51x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESHESTERBIO
Promoter Holding37.67%44.28%
FII Holding17.5% 2.19 pp0.31% 0.07 pp
DII Holding16.11% 0.9 pp0%
Public Holding28.38% 1.28 pp45.95% 0.06 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and HESTER BIOSCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.